Andrea Herschorn1. 1. Omega Medical Associates, 2 Lansing Square, Suite 304, Toronto, ON, Canada. drherschorn@gmail.com
Abstract
OBJECTIVE: To assess the diagnostic accuracy and clinical utility of dermoscopy for melanoma detection in family practice. QUALITY OF EVIDENCE: Ovid MEDLINE (1946 to June 2011), EMBASE, PubMed, and Cochrane databases were searched using the following terms: dermoscopy, dermatoscopy, epiluminescence microscopy, family practice, general practice, primary health care, melanoma, skin neoplasms, and pigmented nevus. To be included, studies had to be primary research articles with family physicians as the subjects and dermoscopy training and use as the intervention. Four papers met all inclusion criteria and provided level I evidence according to the Canadian Task Force on Preventive Health Care definition. MAIN MESSAGE: Among family physicians, dermoscopy has higher sensitivity for melanoma detection than naked-eye examination with generally no decrease in specificity. Dermoscopy also helps to increase family physicians' confidence in their preliminary diagnosis of lesions. When using dermoscopy, compared with naked-eye examination, there is a higher likelihood that a lesion assessed as being malignant is in fact malignant and that a lesion assessed as being benign is in fact benign. CONCLUSION: Dermoscopy has been shown to be a useful and fairly inexpensive tool for melanoma detection in family practice. This technique can increase family physicians' confidence in their referral accuracy to dermatologists and can assist in decreasing unnecessary biopsies. Dermoscopy might be especially useful in examining patients at high risk of melanoma, as the current Canadian clinical practice guideline recommends yearly screening in these individuals.
OBJECTIVE: To assess the diagnostic accuracy and clinical utility of dermoscopy for melanoma detection in family practice. QUALITY OF EVIDENCE: Ovid MEDLINE (1946 to June 2011), EMBASE, PubMed, and Cochrane databases were searched using the following terms: dermoscopy, dermatoscopy, epiluminescence microscopy, family practice, general practice, primary health care, melanoma, skin neoplasms, and pigmented nevus. To be included, studies had to be primary research articles with family physicians as the subjects and dermoscopy training and use as the intervention. Four papers met all inclusion criteria and provided level I evidence according to the Canadian Task Force on Preventive Health Care definition. MAIN MESSAGE: Among family physicians, dermoscopy has higher sensitivity for melanoma detection than naked-eye examination with generally no decrease in specificity. Dermoscopy also helps to increase family physicians' confidence in their preliminary diagnosis of lesions. When using dermoscopy, compared with naked-eye examination, there is a higher likelihood that a lesion assessed as being malignant is in fact malignant and that a lesion assessed as being benign is in fact benign. CONCLUSION: Dermoscopy has been shown to be a useful and fairly inexpensive tool for melanoma detection in family practice. This technique can increase family physicians' confidence in their referral accuracy to dermatologists and can assist in decreasing unnecessary biopsies. Dermoscopy might be especially useful in examining patients at high risk of melanoma, as the current Canadian clinical practice guideline recommends yearly screening in these individuals.
Authors: Giuseppe Argenziano; H Peter Soyer; Sergio Chimenti; Renato Talamini; Rosamaria Corona; Francesco Sera; Michael Binder; Lorenzo Cerroni; Gaetano De Rosa; Gerardo Ferrara; Rainer Hofmann-Wellenhof; Michael Landthaler; Scott W Menzies; Hubert Pehamberger; Domenico Piccolo; Harold S Rabinovitz; Roman Schiffner; Stefania Staibano; Wilhelm Stolz; Igor Bartenjev; Andreas Blum; Ralph Braun; Horacio Cabo; Paolo Carli; Vincenzo De Giorgi; Matthew G Fleming; James M Grichnik; Caron M Grin; Allan C Halpern; Robert Johr; Brian Katz; Robert O Kenet; Harald Kittler; Jürgen Kreusch; Josep Malvehy; Giampiero Mazzocchetti; Margaret Oliviero; Fezal Ozdemir; Ketty Peris; Roberto Perotti; Ana Perusquia; Maria Antonietta Pizzichetta; Susana Puig; Babar Rao; Pietro Rubegni; Toshiaki Saida; Massimiliano Scalvenzi; Stefania Seidenari; Ignazio Stanganelli; Masaru Tanaka; Karin Westerhoff; Ingrid H Wolf; Otto Braun-Falco; Helmut Kerl; Takeji Nishikawa; Klaus Wolff; Alfred W Kopf Journal: J Am Acad Dermatol Date: 2003-05 Impact factor: 11.527
Authors: Paolo Carli; Vincenzo de Giorgi; Alessandra Chiarugi; Paolo Nardini; Martin A Weinstock; Emanuele Crocetti; Marcello Stante; Benvenuto Giannotti Journal: J Am Acad Dermatol Date: 2004-05 Impact factor: 11.527
Authors: Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Rubeta N Matin; Kai Yuen Wong; Roger Benjamin Aldridge; Alana Durack; Abha Gulati; Sue Ann Chan; Louise Johnston; Susan E Bayliss; Jo Leonardi-Bee; Yemisi Takwoingi; Clare Davenport; Colette O'Sullivan; Hamid Tehrani; Hywel C Williams Journal: Cochrane Database Syst Rev Date: 2018-12-04
Authors: Jacqueline Dinnes; Jonathan J Deeks; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Matthew J Grainge; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams Journal: Cochrane Database Syst Rev Date: 2018-12-04
Authors: Jacqueline Dinnes; Jonathan J Deeks; Matthew J Grainge; Naomi Chuchu; Lavinia Ferrante di Ruffano; Rubeta N Matin; David R Thomson; Kai Yuen Wong; Roger Benjamin Aldridge; Rachel Abbott; Monica Fawzy; Susan E Bayliss; Yemisi Takwoingi; Clare Davenport; Kathie Godfrey; Fiona M Walter; Hywel C Williams Journal: Cochrane Database Syst Rev Date: 2018-12-04